Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 30;14(4):e2024241.
doi: 10.5826/dpc.1404a241.

The Prevalence and Clinical Significance of Skin Manifestations in Parkinson's Disease Patients

Affiliations

The Prevalence and Clinical Significance of Skin Manifestations in Parkinson's Disease Patients

Ayşegül Yalçınkaya Iyidal et al. Dermatol Pract Concept. .

Abstract

Background: Parkinson's disease (PD) is primarily characterized by motor symptoms, but non-motor symptoms, including skin manifestations, are increasingly recognized. These remain underexplored despite their potential impact on quality of life.

Objectives: This study aimed to evaluate the prevalence and clinical features of skin findings in PD patients, with a focus on identifying potential pathogenetic links between dermatological conditions and PD.

Methods: A total of 215 PD patients were included. Comprehensive dermatological examinations were performed, and demographic and clinical data were collected. Statistical analysis was conducted using SPSS 23.0, with significance set at P < 0.05.

Results: Skin conditions were found in 92.1% of PD patients. Xerosis, seborrheic dermatitis, and hyperhidrosis were the most common findings. Pre-PD xerosis was associated with an earlier stage of PD (P = 0.001). Use of PD medications, such as levodopa/carbidopa/entacapone, was linked to a lower incidence of seborrheic dermatitis (P = 0.040). A significant correlation was also noted between rosacea and cherry angioma (P = 0.01).

Conclusion: Dermatological conditions are prevalent in PD and may precede its motor symptoms. Skin assessments could aid early diagnosis and management of PD, highlighting the need for further research on their pathogenetic mechanisms.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: None.

References

    1. Ravn A-H, Thyssen JP, Egeberg A. Skin disorders in Parkinson’s disease: potential biomarkers and risk factors. Clin Cosmet Investig Dermatol. 2017;10:87–92. doi: 10.2147/CCID.S130319. - DOI - PMC - PubMed
    1. Shah P, Sagar PR, Alhumaidi N, Bollampally VC, Malik BH. Parkinson’s Disease and Its Dermatological Associations: Is Your Skin Whispering You a Diagnosis? Cureus. 2020;12(8):e9933. doi: 10.7759/cureus.9933. - DOI - PMC - PubMed
    1. Shahid W, Satyjeet F, Kumari R, et al. Dermatological Manifestations of Parkinson’s Disease: Clues for Diagnosis. Cureus. 2020;12(10):e10836. doi: 10.7759/cureus.10836. - DOI - PMC - PubMed
    1. Tomic S, Kuric I, Kuric TG, et al. Seborrheic Dermatitis Is Related to Motor Symptoms in Parkinson’s Disease. J Clin Neurol. 2022;18(6):628–634. doi: 10.3988/jcn.2022.18.6.628. - DOI - PMC - PubMed
    1. Dinesh D, Lee JS, Gao X, Palacios N. Skin conditions in early Parkinson’s disease. Parkinsonism Relat Disord. 2021;84:40–46. doi: 10.1016/j.parkreldis.2021.01.018. - DOI - PMC - PubMed

LinkOut - more resources